Rhino Propels Federated AI into the Enterprise Tech Stack Junshi Biosciences Announces Ongericimab (anti-PCSK9 mAb) Met Primary Endpoints in Two Phase 3 Clinical Studies
SHANGHAI, China, Feb. 27, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”,…
Axiom Exhibiting at Outsourcing in Clinical Trials West Coast 2023
TORONTO, Feb. 27, 2023 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), a premier provider of…
Crossys Coin (CRYS) Is Now Available for Trading on LBank Exchange
Road Town, British Virgin Islands–(Newsfile Corp. – February 27, 2023) – LBank Exchange, a global…
LBank Weekly Listing Report, 27th February 2023
Road Town, British Virgin Islands–(Newsfile Corp. – February 27, 2023) – As a world class…
Genofax(TM) is Using AI Technologies to Recommend Personalised Probiotics(TM) from Individual’s Gut Microbiome Data
New South Wales, Australia–(Newsfile Corp. – February 27, 2023) – GenofaxTM, a biotechnology company specialising…
TANAKA Strengthens Electrical Contact Supply System in China by Making Metalor’s Subsidiary in China a Wholly Owned Subsidiary to Enhance Production Capabilities
TOKYO, Feb 28, 2023 – (JCN Newswire) – TANAKA Kikinzoku Kogyo K.K. (Head office: Chiyoda-ku,…
Tanla Platforms unveils phishing protection platform Wisely ATP at Mobile World Congress, Barcelona 2023
P. D. Vaghela, Chairman, TRAI, launches Wisely ATP at Mobile World Congress 2023 Wisely ATP…
Kioxia and HPE Team Up to Send SSDs into Space, Bound for the International Space Station
HPE Spaceborne Computer-2 Program Features KIOXIA SSDs in the HPE Edgeline Converged Edge System and…
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Tesla, Inc. (TSLA)
SAN DIEGO–(BUSINESS WIRE)–$TSLA #TSLA—The Class: Robbins LLP informs investors that a shareholder filed a class…
Kinetik Reports Fourth Quarter and Full Year 2022 Financial and Operating Results and Provides 2023 Guidance
Generated fourth quarter 2022 net income1 of $48.5 million and Pro Forma Adjusted EBITDA2,3,4 of…
Alvotech Announces Webcast of 2022 Full Year Financial Results at 8:00 am ET on March 2, 2023
Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar…
Alvotech Announces Webcast of 2022 Full Year Financial Results at 8:00 am ET on March 2, 2023
REYKJAVIK, Iceland, Feb. 28, 2023 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company…
Biologics License Application for Lecanemab Designated for Priority Review by China National Medical Products Administration
TOKYO and CAMBRIDGE, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo,…
Crane Holdings, Co. Names Christina Cristiano CFO of Crane NXT
Crane NXT Scheduled to Become Independent Company on April 3, 2023, following Completion of Previously…
OTWO Is Now Available for Trading on LBank Exchange
Road Town, British Virgin Islands–(Newsfile Corp. – February 27, 2023) – LBank Exchange, a global…
Farmland Partners Enacts Senior Executive Succession Plan
Luca Fabbri Succeeds Paul Pittman as CEO and is Appointed to the Board of Directors;…
New Mountain Finance Corporation Announces Financial Results for the Quarter and Year Ended December 31, 2022
Reports Adjusted Net Investment Income of $0.35 per share Declares a First Quarter Distribution to…
Freedom Holding Corp. Russian Divestiture Approved and Completed
Divestiture is of all of Freedom Holding’s businesses in Russia; Company has exited Russia ALMATY,…
Ocugen, Inc. Announces Submission of Investigational New Drug Application with U.S. FDA to Initiate a Phase 1 Clinical Trial Evaluating OCU200 for the Treatment of Diabetic Macular Edema
MALVERN, Pa., Feb. 27, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ:…
Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Option to Purchase Additional Shares
WALTHAM, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc., (Nasdaq: APLS), a global biopharmaceutical…